Given that melanoma is typically not driven by aberrant EGFR expression and/or signaling, this study aimed to clarify the functional and clinical relevance of miR-7-5p in melanoma, and to identify critical pathways through which miR-7-5p acts in this disease. This evidence concerns the gene EGFR and melanoma.